Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Melanocortin System Activates Carotid Body Arterial Chemoreceptors in Hypertension. | Circ Res | 2025 | 40874981 | PubTator, text mining | PubMed |
| Proneural gene Mash1 (Ascl1) is expressed in multiple lineages and regulates their differentiation and specification. | Histochem Cell Biol | 2025 | 40858967 | PubTator, text mining | PubMed |
| Neuropeptide Precursor VGF Promotes Neuroendocrine Differentiation and Cancer-Associated Fibroblast Activation in Small Cell Lung Cancer. | Cancer Res | 2025 | 40857617 | PubTator, text mining | PubMed |
| An iPSC-based in vitro model recapitulates human thymic epithelial development and multi-lineage specification. | Nat Commun | 2025 | 40855082 | PubTator, text mining | PubMed |
| How the diffuse neuroendocrine system shapes health, homeostasis, and cancer. | Front Neuroendocrinol | 2025 | 40854403 | PubTator, text mining | PubMed |
| Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances. | J Exp Clin Cancer Res | 2025 | 40849493 | PubTator, text mining | PubMed |
| Persistent lineage plasticity driving lung cancer development and progression. | Clin Transl Med | 2025 | 40847555 | PubTator, text mining | PubMed |
| Current and Emerging Therapeutic Strategies for Limited- and Extensive-Stage Small-Cell Lung Cancer. | Med Sci (Basel) | 2025 | 40843764 | PubTator, text mining | PubMed |
| Characteristic miRNA profiles represent clinicopathological diversity of small cell lung cancer. | J Pathol | 2025 | 40842416 | PubTator, text mining | PubMed |
| Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study-TCOG T1214 study. | Cancer | 2025 | 40833160 | PubTator, text mining | PubMed |
| Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma. | Nat Commun | 2025 | 40830141 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals metastatic and immunosuppressive characteristics in meningioma brain-tumor interface. | J Transl Med | 2025 | 40826459 | PubTator, text mining | PubMed |
| Controlling gene expression through five zinc finger domains of ZNF18. | Protein Sci | 2025 | 40823929 | PubTator, text mining | PubMed |
| Decoding Pain: Next-Generation In Vitro Systems for Mechanistic Insights and Drug Discovery. | FASEB J | 2025 | 40814286 | PubTator, text mining | PubMed |
| Retraction Notice to: ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancer. | Cell Rep | 2025 | 40783940 | PubTator, text mining | PubMed |
| ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancer. | JCI Insight | 2025 | 40779450 | PubTator, text mining | PubMed |
| SLFN11: a pan-cancer biomarker for DNA-targeted drugs sensitivity and therapeutic strategy guidance. | Front Oncol | 2025 | 40766331 | PubTator, text mining | PubMed |
| Cancer stem cells: landscape, challenges and emerging therapeutic innovations. | Signal Transduct Target Ther | 2025 | 40759634 | PubTator, text mining | PubMed |
| Novel triple-target panels utilizing methylation-sensitive restriction enzyme-based quantitative PCR for detecting advanced cervical precancers and cancers among high-risk HPV-positive women. | J Transl Med | 2025 | 40750892 | PubTator, text mining | PubMed |
| Tet3-mediated DNA demethylation is essential for maintaining the dedifferentiation capacity of mammalian Müller glia. | Front Mol Neurosci | 2025 | 40747242 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=10